Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 12 of 29

COMPLETED NA

Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique

NCT04486560

TERMINATED Phase 2

Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection

NCT04344600

COMPLETED

Non-organic Signs to Predict Outcomes for Neck Pain

NCT04320836

TERMINATED

A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis Pigmentosa

NCT04558983

COMPLETED Phase 2

Convalescent Plasma to Stem Coronavirus (CSSC-001)

NCT04323800

COMPLETED Phase 2

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

NCT04373460

COMPLETED Phase 1

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

NCT04377672

TERMINATED NA

Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation

NCT04344561

COMPLETED

Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic

NCT04374656

TERMINATED Phase 2

Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)

NCT04365257

COMPLETED

Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI)

NCT04496466

COMPLETED Phase 1

Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder

NCT04226352

COMPLETED NA

Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke

NCT06691880

COMPLETED

Association of Mood With Risk for Atherosclerosis

NCT04298944

COMPLETED NA

A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients

NCT03504137

COMPLETED

ChiPP2: A Trauma-Informed Program for City School Parents

NCT04968314

COMPLETED Phase 2

A Study of Standard Drugs for Mycobacterium Avium Complex

NCT04287049

COMPLETED Phase 3

Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

NCT04069312

COMPLETED NA

Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)

NCT03934437

COMPLETED Phase 2

Enhancing Medication-based Analgesia in Humans- STUDY 2

NCT04036968

COMPLETED NA

Contingency Management to Enhance Office-Based Buprenorphine Treatment

NCT04024059

COMPLETED NA

Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury

NCT04073225

COMPLETED NA

Food and Education Effects on Diabetes Study

NCT04034511

TERMINATED NA

Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy

NCT04305379

COMPLETED Phase 1

Tenofovir Rectal Douche to Prevent HIV Transmission

NCT04016233

COMPLETED NA

Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)

NCT04197336

COMPLETED NA

Emotion Regulation Skills Training for Individuals With MS and Their Support Partners

NCT03934489

COMPLETED NA

Depression and Pain Perseverance Through Empowered Recovery Intervention

NCT04091347

COMPLETED NA

Text4Father Pilot Feasibility, Acceptability Study

NCT04101565

COMPLETED Phase 4

Steroid-reducing Effects of Crisaborole

NCT03832010

COMPLETED Phase 1

Brain Imaging in Tobacco Smokers During a Quit Attempt

NCT04055467

COMPLETED Phase 1

Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility

NCT04121338

COMPLETED

Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation

NCT05041712

COMPLETED NA

Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease

NCT04272060

COMPLETED NA

Wakȟáŋyeža (Little Holy One)

NCT04201184

COMPLETED NA

Medication Adherence With Telehealthcare Medication Therapy Management

NCT03978936

COMPLETED NA

Best Rest: Rest Time Before Blood Pressure Measurement Trial

NCT04031768

COMPLETED NA

Ketogenic Diet for Obesity Hypoventilation Syndrome

NCT04108819

TERMINATED NA

Passport to Freedom (P2F): Adaptation and Implementation of a Wellness Program

NCT04069754

COMPLETED Early Phase 1

Pioglitazone for Idiopathic Gastroparesis

NCT04300127

TERMINATED NA

Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain

NCT04040140

COMPLETED NA

Meditation Effects on Brain Function in Rheumatoid Arthritis

NCT03975595

COMPLETED Phase 2

Effects of Sleep Disruption on Drug Response

NCT03680287

COMPLETED NA

Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes

NCT03984058

COMPLETED NA

Effect of Intensivist Communication on Surrogate Prognosis Interpretation

NCT04239209

TERMINATED

Comparison of Magnetic Resonance Coronary Angiography (MRCA) With Coronary Computed Tomography Angiography (CTA)

NCT03768999

COMPLETED

Steroid Eyedrop Adherence After Trabeculectomy

NCT03402802

COMPLETED NA

Comparing Pulmonary Vein Isolation to Pulmonary Vein Isolation + OPTIMA Ablation in Patients Undergoing Ablation for Atrial Fibrillation

NCT04101539

COMPLETED Phase 2

Evolocumab in Patients With Acute MI

NCT04082442

COMPLETED NA

Evaluation of Cellphone Based Otoscopy in Pediatric Patients

NCT04296448

← Previous Page 12 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.